Heron Therapeutics | HRTX - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
ALKERMES USD 543.44M 69.08M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 194.46M 12.23M 2025-12
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 120.59M 13.51M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Surmodics USD 20.54M 347K 2024-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Veracyte USD 59.94M 12.22M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12